Physician profile
Meredith D Hutton
NPI 1861802407
$1,413.45
in general payments reported to CMS, 2019-2025
16 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $377 · 2023: $174 · 2024: $345 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $537.13 | 2021-2025 | |
| Novo Nordisk INC | $281.39 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $113.10 | 2021-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $79.61 | 2022-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $78.42 | 2021-2024 | Mounjaro, Emgality, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $68.21 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $49.31 | 2025 | Caplyta |
| Exact Sciences Corporation | $37.06 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $29.17 | 2021-2025 | |
| Medtronic, INC. | $27.98 | 2022-2024 | Minimed 780g |
| Corcept Therapeutics | $23.12 | 2024 | Korlym |
| Phathom Pharmaceuticals, INC. | $22.18 | 2025 | Voquezna |
| Phadia US INC. | $17.95 | 2021 | |
| Shield Therapeutics INC | $16.72 | 2023 | Accrufer |
| Genentech USA, INC. | $16.22 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $15.88 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Hutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.